DeepMind’s New Model Paves Way For $100 Billion AI Drug Company

Google DeepMind has released a new version of AlphaFold, a landmark tool for predicting protein structures, that puts the artificial intelligence software on a path to make breakthroughs in biology research and bolster a business that Google’s AI chief says could be worth north of $100 billion.

The AI system has the potential to revolutionize medicine and create “enormous commercial value,” for DeepMind spinout Isomorphic Labs, Demis Hassabis, the chief executive officer of both subsidiaries, said in an interview with Bloomberg Television. “I hope to do both with Isomorphic: build a multi-hundred billion dollar business — I think it has that potential — as well as be incredibly beneficial for society and ...